List view / Grid view
14 April 2015 | By Victoria White
Hydra Biosciences and Boehringer Ingelheim have entered into a research collaboration with a primary focus on the treatment of renal diseases and disorders...
18 July 2014 | By Amgen
Analysis shows study met primary and all secondary endpoints AMG 416 is a novel calcimimetic administered intravenously...
7 July 2014 | By Myriad RBM
Collaboration will focus on development of novel diagnostic tests for dialysis patients...
16 June 2014 | By Novo Nordisk
Data from a new phase 3 study demonstrated that once-daily Victoza® (liraglutide) provided greater glycaemic control versus placebo with no worsening of renal function in adults with type 2 diabetes and moderate renal impairment...
